Comparative Pharmacology
Head-to-head clinical analysis: A POXIDE versus HALCION.
Peer-Reviewed Evidence
Head-to-head clinical analysis: A POXIDE versus HALCION.
A-POXIDE vs HALCION
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
GABA-A receptor positive allosteric modulator; increases chloride ion influx and neuronal hyperpolarization.
Triazolam is a benzodiazepine that enhances the effect of GABA at the GABA-A receptor, increasing chloride ion conductance and causing neuronal hyperpolarization, leading to CNS depression.
GERD: 20 mg orally once daily for 4-8 weeks. Erosive esophagitis: 40 mg once daily for 8 weeks. H. pylori eradication: 20 mg twice daily with amoxicillin and clarithromycin for 14 days.
0.25 mg orally once daily at bedtime, maximum 0.5 mg per day.
None Documented
None Documented
Terminal elimination half-life is 12-18 hours (mean 15 hours) in adults with normal renal function. Prolonged to 24-36 hours in elderly or moderate renal impairment (CrCl < 50 mL/min).
Terminal elimination half-life is 1.5–5.5 hours (mean 2.5 hours). Short half-life minimizes next-day sedation.
Renal excretion accounts for 60-70% of elimination, predominantly as unchanged drug. Biliary/fecal excretion accounts for 20-30%, with approximately 10% eliminated in feces as metabolites.
Primarily renal (80%) as conjugated metabolites; fecal (8%); unchanged drug <1%.
Category C
Category C
Benzodiazepine
Benzodiazepine